Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Geron Corp.
Sponsor

Geron Corp.

United States 919 East Hillsdale Boulevard Suite 250, 94404-3296, United States

About the sponsor

Geron Corp. is involved in clinical research for myelofibrosis, with attention to patients who have intermediate-2 or high-risk disease and limited response to JAK-inhibitor therapy. The research landscape includes comparison with current available treatments and evaluation of outcomes relevant to advanced disease control.

  • JAK-inhibitor–refractory myelofibrosis
  • Overall survival
  • Advanced-risk disease

The sponsor’s activity in this area reflects a focus on clinically significant endpoints in a myeloproliferative neoplasm with substantial unmet need.

About Specializations

Geron Corp. runs clinical trials in conditions such as Myelofibrosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Myelofibrosis

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:ALKYLATING AGENTS
  • Sponsor:Geron Corp.

Study of Imetelstat in Patients with Low or Intermediate Risk Myelodysplastic Syndromes (MDS) Refractory to Erythropoiesis-Stimulating Agents

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Imetelstat Sodium
  • Sponsor:Geron Corp.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.